Lactuca capensis reverses memory deficits in Aβ1-42-induced an animal model of Alzheimer's disease
Autor: | Oana Cioanca, Mitica Ciorpac, Paula Alexandra Postu, Monica Hancianu, Marius Mihasan, Jaurès A. K. Noumedem, Brindusa Alina Petre, Dragos Lucian Gorgan, Lucian Hritcu |
---|---|
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
Male antioxidant Interleukin-1beta Gene Dosage Hippocampus IL‐1β Apoptosis Pharmacology Asteraceae Protein Carbonylation chemistry.chemical_compound 0302 clinical medicine Neurotrophic factors Malondialdehyde Spatial Memory brain‐derived neurotrophic factor amyloid Lactuca capensis extract Acetylcholinesterase Glutathione Anesthesia Molecular Medicine Original Article Alzheimer's disease DNA Fragmentation Biology 03 medical and health sciences Alzheimer Disease medicine Animals RNA Messenger Rats Wistar Maze Learning Cholinesterase Brain-derived neurotrophic factor Glutathione Peroxidase Memory Disorders Radial arm maze Amyloid beta-Peptides Plant Extracts Superoxide Dismutase Brain-Derived Neurotrophic Factor Methanol Cell Biology Original Articles medicine.disease Peptide Fragments Plant Leaves Disease Models Animal 030104 developmental biology chemistry biology.protein Cholinergic Cholinesterase Inhibitors 030217 neurology & neurosurgery dementia |
Zdroj: | Journal of Cellular and Molecular Medicine |
ISSN: | 1582-4934 |
Popis: | We investigated the neuropharmacological effects of the methanolic extract from Lactuca capensis Thunb. leaves (100 and 200 mg/kg) for 21 days on memory impairment in an Alzheimer's disease (AD) rat model produced by direct intraventricular delivery of amyloid‐β1‐42 (Aβ1‐42). Behavioural assays such as Y‐maze and radial arm maze test were used for assessing memory performance. Aβ1‐42 decreased cognitive performance in the behavioural tests which were ameliorated by pre‐treatment with the methanolic extract. Acetylcholinesterase activity and oxidant–antioxidant balance in the rat hippocampus were abnormally altered by Aβ1‐42 treatment while these deficits were recovered by pre‐treatment with the methanolic extract. In addition, rats were given Aβ1‐42 exhibited in the hippocampus decreased brain‐derived neurotrophic factor (BDNF) mRNA copy number and increased IL‐1β mRNA copy number which was reversed by the methanolic extract administration. These findings suggest that the methanolic extract could be a potent neuropharmacological agent against dementia via modulating cholinergic activity, increasing of BDNF levels and promoting antioxidant action in the rat hippocampus. |
Databáze: | OpenAIRE |
Externí odkaz: |